Research programme: EP4 receptor agonists - Merck Frosst

Drug Profile

Research programme: EP4 receptor agonists - Merck Frosst

Alternative Names: L-902688

Latest Information Update: 20 Oct 2009

Price : $50

At a glance

  • Originator Merck Frosst
  • Class
  • Mechanism of Action Prostaglandin E4 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Glaucoma

Most Recent Events

  • 27 Sep 2006 Preclinical trials in Glaucoma in Canada (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top